期刊文献+

尼古丁依赖的药物治疗:指南与经验 被引量:11

原文传递
导出
摘要 吸烟是许多疾病的患病危险因素,戒烟可减少很多疾病的发病率及病死率,戒烟困难的原因在于尼古丁的成瘾性。尼古丁依赖是一种慢性高复发性疾病,属于精神神经疾病。有关戒烟指南指出针对戒烟者的尼古丁依赖鼓励使用戒烟药物。戒烟药物包括尼古丁替代药物,安非他酮及尼古丁乙酰胆碱受体α4β2亚型的选择性部分激动药(伐尼克兰),三类药物各有特点。伐尼克兰作为一种新型的戒烟药物,与尼古丁替代疗法(nicotine replacement therapy,NRT)存在不同的特点。我们比较了两者用于临床戒烟的有效性和不良反应,以期指导临床中不同特点戒烟者的尼古丁依赖的治疗。结果显示伐尼克兰应用和NRT都是安全有效的戒烟疗法,药物不良反应各有不同,临床工作中可根据戒烟者自身的不同特点进行相应的选择。
作者 刘晓芳
出处 《临床药物治疗杂志》 2011年第6期25-28,共4页 Clinical Medication Journal
  • 相关文献

参考文献6

  • 1王辰,肖丹,孙永昌,等.2007版中国戒烟临床指南(试行本)[M].北京:人民卫生出版社,20007:12.
  • 2朱倩,李近磊,付文焕,施孝金.戒烟处方药伐尼克兰的有效性及安全性[J].中国新药与临床杂志,2009,28(12):891-894. 被引量:4
  • 3Xiao Y, Lv Y, Zhang X, et al. The pharmacokinetic and tolerabil- ity profile of varenicline in healthy Chinese volunteers[ J]. Inter- national Journal of Clinical Pharmacology Therapeutics, 2009, 47:246- 254.
  • 4Wang C,Xiao D,Chan K P,et al. Varenicline for smoking cessa- tion : a placebo-controlled, randomized study [ J ]. Respirology, 2009, 14:384- 392. 420.
  • 5Aubin H J,Bobak A,Britton J R,et al. Varenicline versus transder, mal nicotine patch for smoking cessation:results from a randomized open-label trial [ J ]. Thorax,2008,63:717- 724.
  • 6West R, Baker C L, Cappelleri J C, et al. Effect of varenicline and bupropion SR on craving, nicotine withdrawal symptoms, and reward- ing effects of smoking during a quit attempt[ J ]. Psychopharmacolo- gy ,2008,197:371 - 377.

二级参考文献23

  • 1XIAO Y, LV Y, ZHANG X, et al. The pharmacokinetics and tolerability profile of varenicline in healthy Chinese volunteers[J]. Int J Clin Pharmacol Ther, 2009, 47(4) : 246-254.
  • 2WANG C, XIAO D, CHAN KP, et al. Varenicline for smoking cessation: a placebo-controlled, randomized study[J]. Respirology, 2009, 14(3): 384-392.
  • 3KASLIWAL R, WILTON LV, SHAKIR SA. Safety and drug utilization profile of varenicline as used in general practice in England: interim resul, ts from a prescription-event monitoringstudy[J]. Drug Saf, 2009, 32(6) : 499-507.
  • 4CAHILL KE, STEAD LY, LANCASTER TM. A preliminary benefit-risk assessment of varenicline in smoking cessation [J]. Drug Saf, 2009, 32(2): 119-135.
  • 5FOULDS JN. The neurobiological basis for partial agonist treatment of nicotine dependence: varenicline[J]. Int J Clin Pract, 2006, 60(5): 571-576.
  • 6porFI'S LA, GARWOOD CL. Varenicline: the newest agent for smoking cessation[J]. Am J Health Syst Pharm, 2007, 64 (13) : 1381-1384.
  • 7OBACH RS, REED-HAGEN AE, KRUEGER SS, et al. Metabolism and disposition of varenicline, a selective alpha4- beta2 acetylcholine receptor partial agonist, in vivo and in vitro [J]. Drug Metab Dispos, 2006, 34( 1 ) : 121-130.
  • 8TONSTAD SA, TφNNESEN PP, HAJEK PR, et al. Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial[J]. JAMA, 2006, 296(1 ): 64-71.
  • 9NAKAMURA M, OSHIMA A, FUJIMOTO Y, et al. Efficacy and tolerability of varenieline, an alpha 4 beta 2 nicotinic aeetyleholine receptor partial agonist, in a 12-week, randomized, placebo-controlled, dose-response study with 40-week fallow-up for smoking cessation in Japanese smokers[J]. ClinTher, 2007, 29 (6): 1040-1056.
  • 10TSAI ST, CHO HJ, CHENG HS, etal. A randomized, placebocontrolled trial of varenicline, a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist, as a new therapy for smoking cessation in Asian smokers[J]. Clin Ther, 2007, 29 (6) : 1027-1039.

共引文献3

同被引文献153

引证文献11

二级引证文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部